Loading
CP
Correvio Pharma Corp. Stock: price and insider trades · Canada
Correvio Pharma Corp.: what insiders have been doing
Correvio Pharma Corp. is a listed company. Its directors and officers file their transactions with SEDI. Nothing new has been filed by managers of Correvio Pharma Corp. in twelve months, the latest record being from 30 March 2020.
Since 2018, the database holds no purchases and 4 sales by insiders of the company.
This summary is built from SEDI disclosures alone and does not predict where the share price will go.
Insider Decl.
11
Thresholds
n/a
Buy Volume
n/a
n/a
Sell Volume
€59,067
4 ops. · all time
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Financial data
· cache
Last declaration on 30 March 2020
Declarations11 total
Common SharesTSXSEDI:3528640
Common SharesTSXSEDI:3525151
8,420 shares@ CA$0.40100.0% of flowCommon SharesTSXSEDI:3465402
10,000 shares@ CA$4.9858.6% of flowCommon SharesTSXSEDI:3226037
5,603 shares@ CA$3.8224.4% of flowCommon SharesTSXSEDI:3202967
4,000 shares@ CA$3.7216.9% of flowCommon SharesTSXSEDI:3202189
Common SharesTSXSEDI:3202187
Common SharesTSXSEDI:3200112
Common SharesTSXSEDI:3200083
Common SharesTSXSEDI:3200087
Common SharesTSXSEDI:3200098
11 of 11 declarations
About Correvio Pharma Corp.
Correvio Pharma Corp. is a pharmaceutical company focused on developing treatments for cardiovascular diseases. It is listed on the Toronto Stock Exchange under the symbol XTSE.
